Pomelo Care Secures $92M, Expands Virtual Care to Transform Women's and Children's Health
January 11, 2026, 3:38 am
Pomelo Care raised $92 million in Series C funding. This solidifies a $1.7 billion valuation. The company is now expanding its virtual care model. It moves beyond maternity. New programs address comprehensive women's and children's health needs. Pomelo’s data-driven approach delivers proven outcomes. Preterm births are down 37%. ER visits dropped 46%. NICU stays are reduced. This model offers significant ROI for payers. It tackles care access gaps across the U.S. healthcare system. Pomelo becomes a vital infrastructure partner. It sets new standards for value-based outcomes. The company continues to redefine healthcare delivery.
Pomelo Care announces a major funding round. The digital health innovator secured $92 million in Series C funding. This elevates its valuation to $1.7 billion. The investment signals strong market confidence. It validates Pomelo’s impact on healthcare. The capital infusion fuels ambitious expansion plans. Pomelo will broaden its virtual care model. It moves beyond its foundational maternity services. The company now targets comprehensive women's and children's health. This includes reproductive health, pediatrics, and midlife care.
The funding round saw strong participation. Stripes led the investment. Andreessen Horowitz also contributed. PLUS Capital, Atomico, BoxGroup, and SV Angel joined. These investors recognize Pomelo’s proven success. The company, founded in 2021, grew rapidly. It now covers over 25 million lives nationwide. Pomelo supports a significant portion of U.S. births. Nearly 7% of American babies benefit from its virtual model.
Pomelo’s model emphasizes evidence-based care. It utilizes a 24/7 virtual platform. A multispecialty clinical team delivers services. This team includes nurses, dietitians, therapists, and doulas. Providers can diagnose, treat, and manage care remotely. The platform supports multiple access points. Patients connect via phone, text, video, or app. This accessibility bridges critical care gaps. It addresses clinician capacity constraints effectively.
The company's intelligent care platform is central. It embeds evidence-based pathways. Predictive analytics guide clinician workflows. This system identifies risks early. It updates care plans as a patient's journey evolves. Continuous monitoring complements this data-driven approach. Care coordination with in-person providers remains crucial. This hybrid model ensures comprehensive support.
Pomelo boasts impressive, claims-based results. These outcomes are peer-reviewed. They are presented at national scientific conferences. Preterm births saw a 37% reduction. This is a critical metric in maternal health. Emergency room utilization decreased by 46%. This lowers costs and improves patient safety. NICU length of stay dropped by 6.8 days. Complex cases saw an even greater reduction of 16.3 days.
Maternal mental health also improved. Prenatal depression screening rates soared. They increased by 718% compared to national averages. Follow-up rates also saw similar gains. These clinical milestones translate into economic benefits. Pomelo delivers a 3-5x return on investment. Payers and employers see substantial savings. These savings stem from reduced preterm births, ER visits, and NICU stays.
The new funding supports significant strategic shifts. Pomelo will scale its existing maternity offering. It will also apply its accountability framework to new programs. Reproductive health services are coming. Pediatric care is a key focus. Hormonal health programs will launch. The Midlife Care Program is particularly notable. It targets perimenopause and menopause challenges.
Early results from the Midlife Care Program are promising. Patients reported an 88% reduction in symptoms. This improvement occurred within 60 days. Workplace productivity also saw gains. 73% of patients noted increased productivity. These figures highlight the program's effectiveness. They address underserved needs in women's health.
Pomelo aims to tackle "care deserts." Many regions in the U.S. lack adequate healthcare access. Virtual care provides a powerful solution. It extends specialist care to remote areas. This ensures more equitable access. The company positions itself as a lifelong women’s health hub. It moves beyond a "maternity startup" label.
Pomelo is becoming a category-leading infrastructure partner. Payers like UnitedHealthcare and Aetna demand value-based outcomes. Pomelo's published, claims-based results set a high bar. Competitors must now meet or exceed these standards. The company's model proves data-driven care is sustainable. It benefits patients, payers, providers, and employers alike.
Proactive healthcare is key to its success. It leverages technology to improve outcomes. It lowers costs across the entire healthcare ecosystem. Pomelo is redefining how care is delivered. It addresses critical health needs across the lifespan. The future of American healthcare demands such innovation. Pomelo Care is at the forefront of this transformation.
Pomelo Care announces a major funding round. The digital health innovator secured $92 million in Series C funding. This elevates its valuation to $1.7 billion. The investment signals strong market confidence. It validates Pomelo’s impact on healthcare. The capital infusion fuels ambitious expansion plans. Pomelo will broaden its virtual care model. It moves beyond its foundational maternity services. The company now targets comprehensive women's and children's health. This includes reproductive health, pediatrics, and midlife care.
The funding round saw strong participation. Stripes led the investment. Andreessen Horowitz also contributed. PLUS Capital, Atomico, BoxGroup, and SV Angel joined. These investors recognize Pomelo’s proven success. The company, founded in 2021, grew rapidly. It now covers over 25 million lives nationwide. Pomelo supports a significant portion of U.S. births. Nearly 7% of American babies benefit from its virtual model.
Pomelo’s model emphasizes evidence-based care. It utilizes a 24/7 virtual platform. A multispecialty clinical team delivers services. This team includes nurses, dietitians, therapists, and doulas. Providers can diagnose, treat, and manage care remotely. The platform supports multiple access points. Patients connect via phone, text, video, or app. This accessibility bridges critical care gaps. It addresses clinician capacity constraints effectively.
The company's intelligent care platform is central. It embeds evidence-based pathways. Predictive analytics guide clinician workflows. This system identifies risks early. It updates care plans as a patient's journey evolves. Continuous monitoring complements this data-driven approach. Care coordination with in-person providers remains crucial. This hybrid model ensures comprehensive support.
Pomelo boasts impressive, claims-based results. These outcomes are peer-reviewed. They are presented at national scientific conferences. Preterm births saw a 37% reduction. This is a critical metric in maternal health. Emergency room utilization decreased by 46%. This lowers costs and improves patient safety. NICU length of stay dropped by 6.8 days. Complex cases saw an even greater reduction of 16.3 days.
Maternal mental health also improved. Prenatal depression screening rates soared. They increased by 718% compared to national averages. Follow-up rates also saw similar gains. These clinical milestones translate into economic benefits. Pomelo delivers a 3-5x return on investment. Payers and employers see substantial savings. These savings stem from reduced preterm births, ER visits, and NICU stays.
The new funding supports significant strategic shifts. Pomelo will scale its existing maternity offering. It will also apply its accountability framework to new programs. Reproductive health services are coming. Pediatric care is a key focus. Hormonal health programs will launch. The Midlife Care Program is particularly notable. It targets perimenopause and menopause challenges.
Early results from the Midlife Care Program are promising. Patients reported an 88% reduction in symptoms. This improvement occurred within 60 days. Workplace productivity also saw gains. 73% of patients noted increased productivity. These figures highlight the program's effectiveness. They address underserved needs in women's health.
Pomelo aims to tackle "care deserts." Many regions in the U.S. lack adequate healthcare access. Virtual care provides a powerful solution. It extends specialist care to remote areas. This ensures more equitable access. The company positions itself as a lifelong women’s health hub. It moves beyond a "maternity startup" label.
Pomelo is becoming a category-leading infrastructure partner. Payers like UnitedHealthcare and Aetna demand value-based outcomes. Pomelo's published, claims-based results set a high bar. Competitors must now meet or exceed these standards. The company's model proves data-driven care is sustainable. It benefits patients, payers, providers, and employers alike.
Proactive healthcare is key to its success. It leverages technology to improve outcomes. It lowers costs across the entire healthcare ecosystem. Pomelo is redefining how care is delivered. It addresses critical health needs across the lifespan. The future of American healthcare demands such innovation. Pomelo Care is at the forefront of this transformation.